Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT00348894
Previous Study | Return to List | Next Study

[S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00348894
Recruitment Status : Terminated (- Study was terminated due to insufficient clinical efficacy observed in previous studies conducted in postherpetic neuralgia.)
First Posted : July 6, 2006
Last Update Posted : June 1, 2011
Sponsor:
Information provided by:
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : October 2007
Actual Study Completion Date : October 2007